LinkedInYouTubeFacebookInstagramTwitter

High-Throughput Imaging Assessing Virus-Neutralizing Activity of Sera from Vaccinated Individuals

The severe acute respiratory coronavirus 2 (SARS-CoV-2) has caused the ongoing COVID-19 pandemic, infecting more than 206 million people and causing upwards of 4.34 million deaths at the time of writing.

By |2022-01-31T21:34:47+00:00December 3rd, 2021|Categories: Celigo, Latest News, Virology|Tags: , , , , , |0 Comments
Read More

High-Throughput Viral Titer Analysis

There are many methods to determine a viral titer, with each having its pros and cons, however the increasing need to have high throughput methods to determine viral titers are ever-pressing.

By |2022-01-31T21:32:39+00:00November 4th, 2020|Categories: Celigo, Instrument, Latest News, Virology|Tags: , , , , , , , , |0 Comments
Read More
Nexcelom Bioscience LLC. | 360 Merrimack Street, Suite 200 | Lawrence, MA 01843 USA Telephone: +1 978.327.5340 | www.nexcelom.com © 2003-2023 Nexcelom Bioscience LLC. All Rights Reserved. Nexcelom products are for RESEARCH USE ONLY and are not approved for diagnostic or therapeutic use.
LinkedInYouTubeFacebookInstagramTwitter
Go to Top